USPTO serial 86234440
ABZENA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 19, 2015
- Examiner
- LOTT, MAUREEN DALL
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.
Need help with ABZENA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mainak H. Mehta
Mainak H. Mehta Procopio, Cory, Hargreaves & Savitch LLP525 B Street, Suite 2200San Diego, CA 92101United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in manufacturing pharmaceuticals; Chemical preparations for use in the manufacture of pharmaceuticals; Chemicals for use in the pharmaceutical industry; chemicals for use in the pharmaceutical industry, namely, intermediates for pharmaceuticals; intermediates being chemicals for use in industry, namely, chemicals for use in the manufacture of pharmaceuticals | ACTIVE | — |
| 005 | Pharmaceuticals, pharmaceutical compositions, and pharmaceutical preparations, used to treat cancer, diseases of the immune system, viral infections, HIV, Influenza, inflammatory diseases, fibrotic diseases, pulmonary diseases, blood disorders, neurodegenerative diseases, graft rejection; chemical preparations for medical or pharmaceutical purposes, namely, chemicals sold as integral component parts of pharmaceutical preparations for the treatment of cancer, diseases of the immune system, viral infections, HIV, Influenza, inflammatory diseases, fibrotic diseases, pulmonary diseases, blood disorders, neurodegenerative diseases, graft rejection; chemico-pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of cancer, diseases of the immune system, viral infections, HIV, Influenza, inflammatory diseases, fibrotic diseases, pulmonary diseases, blood disorders, neurodegenerative diseases, graft rejection | ACTIVE | — |
| 042 | Scientific research and product development services in relation to pharmaceutical and medical products; scientific services, namely, product development in the field of pharmaceuticals; research, namely, scientific research and product development in the field of pharmaceuticals; industrial research in the field of pharmaceuticals; product design in the field of pharmaceuticals; Pharmaceutical research services; Pharmaceutical product evaluation; Testing of pharmaceuticals; Pharmaceutical drug development services; Development of pharmaceutical preparations and medicines; Providing medical and scientific research information in the field of pharmaceuticals; provision of scientific information in the fields of cancer, diseases of the immune system, viral infections, HIV, Influenza, inflammatory diseases, fibrotic diseases, pulmonary diseases, blood disorders, neurodegenerative diseases, graft rejection; providing of scientific information regarding pharmaceuticals and medicines; provision of scientific information relating to the chemical industry, namely, information on the subject of chemical product development | ACTIVE | — |
| 044 | Medical services, namely, providing medical information regarding pharmaceuticals; pharmaceutical services and provision of pharmaceutical information, all in the nature of providing medical information regarding pharmaceuticals; providing to others a collection of information, namely, providing medical information relating to the use of pharmaceuticals | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PolyTherics Ltd.
- Other trademarks owned by PolyTherics Ltd.
- Other trademarks owned by PolyTherics Ltd.
- Other trademarks owned by ABZENA (UK) LIMITED
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ABZENA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 9, 2025 | NA89 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | — |
| Sep 9, 2025 | RNL1 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| Sep 9, 2025 | 89AG | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | The USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary. |
| Sep 9, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| May 9, 2025 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| May 19, 2024 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Sep 21, 2021 | NAS8 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | — |
| Sep 21, 2021 | 8.OK | REGISTERED - SEC. 8 (6-YR) ACCEPTED | The USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline. |
| Sep 21, 2021 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| May 18, 2021 | ES8R | TEAS SECTION 8 RECEIVED | — |
| May 19, 2020 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jul 31, 2019 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Apr 4, 2016 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 19, 2015 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 3, 2015 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 3, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 11, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 23, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jan 22, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 22, 2015 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 22, 2015 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 22, 2015 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 22, 2015 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 21, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 20, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 20, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 15, 2014 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 15, 2014 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 15, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 24, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 24, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 24, 2014 | ALIE | ASSIGNED TO LIE | — |
| Nov 20, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 28, 2014 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 28, 2014 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 28, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 28, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 10, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 31, 2014 | NWAP | NEW APPLICATION ENTERED | — |